open access

Vol 84, No 1 (2013)
ARTICLES
Get Citation

Statement of the Polish Gynecological Society Expert Group on the use of iron preparations (Tardyferon, Tardyferon-Fol) in obstetrics and gynaecology

Ginekol Pol 2013;84(1).

open access

Vol 84, No 1 (2013)
ARTICLES

Abstract

According to the literature data, approximately 700 million people worldwide have overt or latent iron deficiency. This is related to nutrition. The highest risk groups, apart from children, are pregnant women (50–60%) and young women of childbearing age (20–40%). Anaemia is a hazard for pregnant and parturient women, as well as for the foetus and newborn. In pregnant women, pharmacological treatment should be initiated if parameters such as haemoglobin, iron and ferritin levels indicate existing iron deficiency or overt anaemia. Treatment should be administered in each period of pregnancy. Commonly recommended anaemia management includes two actions:  a diet rich in iron and therapy with preparations containing iron with folic acid. Oral, well-tolerated and sustainedrelease iron products are preferred. Formulations containing divalent iron, slowly-absorbed, causing no  astrointestinal intolerance, which are available on the Polish market, include Tardyferon and  Tardyferon-Fol. These products fully meet WHO requirements for recommended daily intake of elemental iron in patients with anaemia or iron deficiency. In the opinion of the Polish Gynaecological Society Panel of Experts, iron preparations Tardyferon and Tardyferon-Fol are effective therapeutic options for the prevention and treatment of iron deficiency anaemia.

Abstract

According to the literature data, approximately 700 million people worldwide have overt or latent iron deficiency. This is related to nutrition. The highest risk groups, apart from children, are pregnant women (50–60%) and young women of childbearing age (20–40%). Anaemia is a hazard for pregnant and parturient women, as well as for the foetus and newborn. In pregnant women, pharmacological treatment should be initiated if parameters such as haemoglobin, iron and ferritin levels indicate existing iron deficiency or overt anaemia. Treatment should be administered in each period of pregnancy. Commonly recommended anaemia management includes two actions:  a diet rich in iron and therapy with preparations containing iron with folic acid. Oral, well-tolerated and sustainedrelease iron products are preferred. Formulations containing divalent iron, slowly-absorbed, causing no  astrointestinal intolerance, which are available on the Polish market, include Tardyferon and  Tardyferon-Fol. These products fully meet WHO requirements for recommended daily intake of elemental iron in patients with anaemia or iron deficiency. In the opinion of the Polish Gynaecological Society Panel of Experts, iron preparations Tardyferon and Tardyferon-Fol are effective therapeutic options for the prevention and treatment of iron deficiency anaemia.
Get Citation

Keywords

iron preparations, pregnancy, Anaemia

About this article
Title

Statement of the Polish Gynecological Society Expert Group on the use of iron preparations (Tardyferon, Tardyferon-Fol) in obstetrics and gynaecology

Journal

Ginekologia Polska

Issue

Vol 84, No 1 (2013)

Bibliographic record

Ginekol Pol 2013;84(1).

Keywords

iron preparations
pregnancy
Anaemia

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl